In clinical field trials with Cardotek-30 Plus, vomiting or diarrhea within 24 hours of dosing was rarely observed (1.1% of administered doses). The following adverse reactions have been reported following the use of HEARTGARD: Depression/lethargy, vomiting, anorexia, diarrhea, mydriasis, ataxia, staggering, convulsions and hypersalivation.

REVIEWS

In clinical field trials with Cardotek-30 Plus, vomiting or diarrhea
In clinical field trials with Cardotek-30 Plus, vomiting or diarrhea

The results of a survey conducted on ndrugs.com for Cardotek-30 Plus are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Cardotek-30 Plus. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

Cardotek-30 (ivermectin) is indicated for the treatment of the following infections:

Strongyloidiasis of the intestinal tract. Cardotek-30 (ivermectin) is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis.

This indication is based on clinical studies of both comparative and open-label designs, in which 64-100% of infected patients were cured following a single 200-mcg/kg dose of ivermectin.

Onchocerciasis. Cardotek-30 (ivermectin) is indicated for the treatment of onchocerciasis due to the nematode parasite Onchocerca volvulus.

This indication is based on randomized, double-blind, placebo-controlled and comparative studies conducted in 1427 patients in onchocerciasis-endemic areas of West Africa. The comparative studies used diethylcarbamazine citrate (DEC-C).

NOTE: Cardotek-30 (ivermectin) has no activity against adult Onchocerca volvulus parasites. The adult parasites reside in subcutaneous nodules which are infrequently palpable. Surgical excision of these nodules (nodulectomy) may be considered in the management of patients with onchocerciasis, since this procedure will eliminate the microfilariae-producing adult parasites.

Important safety information:

  • Cardotek-30 may cause dizziness or drowsiness. These effects may be worse if you take it with alcohol or certain medicines. Use Cardotek-30 with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.
  • Cardotek-30 may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.
  • Rarely, some patients taking Cardotek-30 who have also had a certain other parasite infection have developed a serious and sometimes fatal brain problem. Tell your doctor if you have any other parasite infection. Tell your doctor if you have been in an area where Loa loa infection is likely (eg, West or Central Africa). Tell your doctor at once if you have symptoms such as unusual back pain, eye bleeding, shortness of breath, failure to control bladder or bowel, trouble walking or standing, mental changes (eg, confusion), unusual weakness, or seizures.
  • Lab tests, including stool examinations, may be performed while you use Cardotek-30. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.
  • Cardotek-30 should be used with extreme caution in CHILDREN weighing less than 33 pounds (15 kilograms); safety and effectiveness in these children have not been confirmed.
  • PREGNANCY and BREAST-FEEDING: Do not use Cardotek-30 if you are pregnant. If you think you may be pregnant, contact your doctor right away. Cardotek-30 is found in breast milk. If you are or will be breast-feeding while you use Cardotek-30, check with your doctor. Discuss any possible risks to your baby. If you are not worried about more pain in your heart, then you can withstand heavy loads at a new job, and the best vacancies can be found on this site – https://jobstellar.com/uk/